参松养心胶囊联合美托洛尔治疗冠心病室性早搏的临床效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (547 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the clinical effect of Shensong Yangxin Capsules combined with Metoprolol in the treatment of premature ventricular contractions in coronary heart disease. Methods A total of 60 patients with premature ventricular beats of coronary heart disease admitted to the Department of Cardiology，Heilongjiang College of Traditional Chinese Medicine From December 2019 to April 2021 were selected as the research subjects，and were divided into control group (30 cases) and treatment group (30 cases) according to random number table method. The control group was treated with conventional western medicine combined with Metoprolol，and the treatment group was treated with Shensong Yangxin Capsules on the basis of the control group. Traditional Chinese medicine (TCM)syndrome score，plasma N-terminal B-type natriuretic peptide (NT-proBNP)，angiotensin Ⅱ(Ang Ⅱ)，number of 24 h premature pulse and cardiac function indexes (left ventricular end systolic diameter [LVESD]，left ventricular end diastolic diameter [LVEDD]，left ventricular ejection fraction [LVEF]) were compared between the two groups. Results There was no significant difference in TCM syndrome score between the two groups before treatment (P＞0.05). After treatment，TCM syndrome scores of both groups were lower than before，and the treatment group was lower than the control group，the difference was statistically significant (P＜0.05). There was no significant difference in the levels of NT-proBNP and Ang Ⅱbetween two groups before treatment (P＞0.05). After treatment，the serum levels of NTproBNP and Ang Ⅱin both groups were lower than before，and the treatment group was lower than the control group，the differences were statistically significant (P＜0.05). There was no significant difference in the number of premature pulse 24 h before treatment between the two groups (P＞0.05). After treatment，the number of 24 h premature pulse in both groups was less than before，and the number of 24 h premature pulse in the treatment group was less than the control group，the difference was statistically significant (P ＜0.05). There was no significant difference in cardiac function indexes between the two groups before treatment (P＞0.05). After treatment，LVESD and LVEDD in the two groups were lower than before，and LVEF was higher than before，and LVESD and LVEDD in the treatment group were lower than the control group，and LVEF was higher than the control group，the differences were statistically significant(P＜0.05). Conclusion Shensong Yangxin Capsules combined with Metoprolol has obvious effect in the treatment of ventricular premature beat of coronary heart disease，which can improve the clinical symptoms of traditional Chinese medicine，improve NT proBNP and Ang Ⅱindexes，reduce the number of premature beats and improve cardiac function，which is worthy of promotion.

Key words： Coronary heart disease Ventricular premature beat Shensong Yangxin Capsules Metoprolol Curative effect analysis Cardiac function

Received: 13 July 2021

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors

Cite this article:

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2022/V29/I1/60

[1]	赵雅静，刘明辉，王彦丽，等.辛伐他汀联合曲美他嗪对冠心病心绞痛血液流变学、血管内皮功能和炎症因子的影响[J].湖南师范大学学报（医学版），2020，17（5）：166-169.
[2]	吴岚，揭珏，周琛，等.参松养心胶囊联合美托洛尔治疗冠心病室性早搏效果及对相关指标的影响[J].白求恩医学杂志，2020，18（3）：263-265.
[3]	Tang PT，Shenasa M，Boyle NG.Ventricular Arrhythmias and Sudden Cardiac Death[J].Card Electrophysiol Clin，2017，9（4）：693-708.
[4]	杜建英，韩素华，李国平.室性早搏形态改变与冠脉病变及其严重程度关系探讨[J].中西医结合心脑血管病杂志，2016，14（5）：518-522.
[5]	王温，钟山，陈朝露.参松养心胶囊联合美托洛尔治疗冠心病室性早搏疗效观察[J].现代中西医结合杂志，2019，28（29）：3260-3263.
[6]	付玲，邹飞虎，罗玲.定悸复脉汤抗室性心律失常的疗效观察[J].中国中医急症，2019，28（6）：1073-1075.
[7]	葛均被，徐永健，梅长林，等.内科学[M].8 版.北京：人民卫生出版社，2013：344-345.
[8]	中华医学会心电生理和起搏分会，中国医师协会心律学专业委员会.2020 室性心律失常中国专家共识解读[J].中华心律失常学杂志，2020，24（4）：348-350.
[9]	中华人民共和国卫生部.中药新药临床研究指导原则[M].北京：人民卫生出版社，1997：108-110.
[10]	国家中医药管理局.中医病证诊断疗效标准[M].南京：南京大学出版社，1994：112
[11]	彭媛媛.参芎定悸方治疗冠心病室性早搏气虚血瘀型患者临床疗效观察及对心率震荡的影响[D].哈尔滨：黑龙江中医药大学，2020：11.
[12]	刘华明，林应华，刘丽梅，等.桂枝甘草龙骨牡蛎加味汤加减对冠心病室性早搏患者心脏射血分数和心肌酶水平影响[J].四川中医，2020，38（12）：66-69.
[13]	吴欣芳，吴宝，王吉元，等.升陷汤加味治疗冠心病室性早搏临床研究[J].陕西中医，2020，41（11）：1563-1565.
[14]	张利，蒋维晏，刘春援.参松养心胶囊药理作用及临床应用研究进展[J].江西中医药，2014，12：70-72.
[15]	徐婧熙，程晓昱，葛岚.参松养心胶囊治疗慢性心力衰竭合并室性早搏疗效和安全性的Meta 分析[J].安徽医药，2018，22（1）：122-126.